Overview
- The company detected a cybersecurity incident on Tuesday, August 25, and in response filed an SEC Form 8-K to notify investors while activating its incident response plan.
- The breach has restricted access to key IT systems and business applications that the company uses to process customer orders and ship products, forcing operational limits across its global network.
- Boston Scientific has hired third-party cybersecurity experts to contain the intrusion and run forensics, but it has not disclosed the type of attack, whether data was removed, or the identity of any attacker.
- Shares fell in early trading after the disclosure and local operations in Ireland reported network outages that sent thousands of staff to work from home or go home for the day.
- The incident fits a wider 2026 pattern of medtech breaches and could cause ripple effects for hospitals and scheduled care if shipments remain delayed while the company assesses operational and financial impact.